newsfilter
← Latest News
GlobeNewswire·

Akouos to Present at the American Society of Gene and Cell Therapy 25th Annual Meeting

BOSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Akouos, Inc. (NASDAQ:AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that new nonclinica